Pfizer advances bold vision for future of cancer care at the ASCO 2025 annual meeting: New York Friday, April 25, 2025, 10:00 Hrs [IST] Pfizer Inc. will showcase data across its p ...

DelveInsight's "IBRANCE Market Size, Forecast, and Market Insight Report" highlights the details around IBRANCE, a CDK4/6 ...

Pfizer Inc. (NYSE: PFE) will showcase data across its portfolio of potential breakthrough cancer medicines at the 2025 American Society of Clinical ...

Pfizer (PFE) will showcase data across its portfolio of potential breakthrough cancer medicines at the 2025 American ...

Arvinas, Inc. (NASDAQ: ARVN) recently presented data from the first-in-human clinical trial of arv-102, the company’s investigational proteolysis targeting chimera (protac) leucine-rich repeat kinase ...

Pfizer has increased its dividend for 16 straight years, and its dividend yield was recently a fat 7.1%, meaning that a $1,000 position in the stock would generate $71 over a year.

Stocks like Pfizer, Amgen, Johnson & Johnson, and Eli Lilly & Co. were among others which opened lower after the US stock market opened on Wednesday. Pfizer Inc. shares are currently trading 2.56 ...

Pharmaceutical giant Pfizer sold its longtime San Diego campus to a life science-focused commercial real estate company in one of the largest deals of the past year. Pfizer sold the five ...

Pfizer Inc.’s longtime chief scientist is joining Blackstone Inc. to advise the private equity giant on its investments into advanced new medicines. Mikael Dolsten, who retired from Pfizer late ...

Pfizer and AbbVie shares declined more than 4%, Merck dropped almost 4%, and Eli Lilly pulled back over 3% in early trading. Daily Merck & Company, Inc. Dow pharmaceutical components are leading ...

(The company is about to be split into two entities.) A leader in protein degradation therapeutics, Arvinas Inc has a US$438 million market cap, with US$1.039 bullion cash and no debt – a ...